Latest News On Insurers

Latest California Healthline Stories

Must-Reads Of The Week From Brianna Labuskes

Happy Friday! In news that is technically really good and exciting but is also kind of icky: yarn made from human skin could eventually be used to stitch up surgical wounds as a way to cut down on detrimental reactions from patients. As CNN reports, “The researchers say their ‘human textile,’ which they developed from […]

Patients Stuck With Bills After Insurers Don’t Pay As Promised

Insurance companies often require patients to have medical procedures, devices, tests and even some medicines preapproved to ensure the insurers are willing to cover the costs. But that doesn’t guarantee they’ll end up paying. Some patients are getting stuck with unexpected bills after the medical service has been provided.

Patients Caught In Crossfire Between Giant Hospital Chain, Large Insurer

Insurance giant Cigna and San Francisco-based Dignity Health have failed to ink a 2020 contract, leaving nearly 17,000 patients in California and Nevada scrambling to find new health care providers. Meanwhile, Dignity faces financial and legal challenges while it strives to implement its merger with Catholic Health Initiatives, which created one of the nation’s largest Catholic hospital systems.

Appendicitis Is Painful — Add A $41,212 Surgery Bill To The Misery

A young man averted medical disaster after a friend took him to the nearest hospital just before his appendix burst. But more than a year later, he’s still facing a $28,000 balance bill for his out-of-network surgery.

Le cobran $41,212 por sacarle el apéndice

Nadie le dijo que el hospital estaba fuera de la red del plan médico que tenía a través de su trabajo. En cualquier caso, no hubiera podido irse a otro lugar. Su apéndice estaba a punto de reventar.

Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers

A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.